We are live on ! Find out more
SM

Sabby Management Portfolio holdings

AUM $45.1M
1-Year Est. Return 74.25%
This Fund
S&P 500
This Quarter Est. Return
-34.3%
1 Year Est. Return
-74.25%
3 Year Est. Return
-95.86%
5 Year Est. Return
-99.36%
10 Year Est. Return
-99.46%
AUM
$115M
AUM Growth
+$792K
Cap. Flow
+$6.43M
Cap. Flow %
5.6%
Top 10 Hldgs %
83.12%
Holding
142
New
32
Increased
15
Reduced
32
Closed
53

Top Buys

Rank Stock Value
1
RCON icon
Recon Technology
RCON
+$5M
2
GMVD
G Medical Innovations Holdings Ltd. Ordinary Shares
GMVD
+$3.87M
3
BETS
Bit Brother Limited Class A Ordinary Shares
BETS
+$2.24M
4
CNEY icon
CN Energy Group
CNEY
+$2.19M
5
NMTR
9 Meters Biopharma
NMTR
+$2.08M

Top Sells

Rank Stock Value
1
NVCT icon
Nuvectis Pharma
NVCT
+$4.41M
2
TBLT
ToughBuilt Industries, Inc. Common Stock
TBLT
+$2.28M
3
IWM icon
iShares Russell 2000 ETF
IWM
+$1.92M
4
BGXX
Bright Green Corporation Common Stock
BGXX
+$1.49M
5
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$1.34M

Sector Composition

Rank Sector Weight
1 Healthcare 9.81%
2 Technology 3.12%
3 Consumer Discretionary 2.1%
4 Communication Services 1.53%
5 Materials 1.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CRIS icon
101
Curis
CRIS
$9.73M
– –
-565
Closed -$124K
CYN icon
102
Cyngn
CYN
$15.1M
– –
-5
Closed -$44.8K
CHRN
103
ChronoScale Holdings
CHRN
$2.71B
– –
-6,827
Closed -$122K
ESPR
104
PUT
DELISTED
Esperion Therapeutics
ESPR
– –
-1,179
Closed -$735K
GEVO icon
105
CALL
Gevo
GEVO
$353M
– –
-403
Closed -$76.6K
GFAIW icon
106
Guardforce AI Warrant
GFAIW
$94.5K
– –
-388,000
Closed -$7.76K
GNLN icon
107
Greenlane Holdings
GNLN
$1.06M
– –
-1
Closed -$145K
GWAV icon
108
Greenwave Technology Solutions
GWAV
$2.36M
– –
-17
Closed -$243K
IBIO icon
109
iBio
IBIO
$69.1M
– –
-24,523
Closed -$631K
IMPP icon
110
PUT
Imperial Petroleum
IMPP
$213M
– –
-10
Closed -$3.71K
IVDA icon
111
Iveda Solutions
IVDA
$2.78M
– –
-23,679
Closed -$105K
IWM icon
112
iShares Russell 2000 ETF
IWM
$79.2B
– –
-11,000
Closed -$1.92M
NMAD
113
Nomad Power Solutions
NMAD
$73.5M
– –
-9,964
Closed -$50.7K
LSTA icon
114
Lisata Therapeutics
LSTA
$10.4M
– –
-68,462
Closed -$173K
LUCY icon
115
Innovative Eyewear
LUCY
$6.05M
– –
-3,750
Closed -$103K
NCTY
116
The9 Ltd
NCTY
$66.3M
– –
-1,445
Closed -$8.2K
NVCT icon
117
Nuvectis Pharma
NVCT
$653M
– –
-587,452
Closed -$4.41M
ONCO icon
118
Onconetix
ONCO
$2.78M
– –
-3
Closed -$620K
PMCB icon
119
PharmaCyte Biotech
PMCB
$6.29M
– –
-97,978
Closed -$287K
RDHL
120
Redhill Biopharma
RDHL
$4.26M
– –
-7,450
Closed -$1.05M
SBEV icon
121
Splash Beverage Group
SBEV
$2.03M
– –
-177
Closed -$27.2K
SBEV.WS
122
DELISTED
Splash Beverage Group, Inc. Warrants to purchase 1/40th of a share of Common Stock at an exercise price of $184.00
SBEV.WS
– –
-239,961
Closed -$36K
SPY icon
123
State Street SPDR S&P 500 ETF Trust
SPY
$773B
– –
-3,350
Closed -$1.34M
WLDS icon
124
Wearable Devices
WLDS
$6.66M
– –
-951
Closed -$299K
ZVRA icon
125
Zevra Therapeutics
ZVRA
$578M
– –
-70,000
Closed -$321K
2 3 4
5
6

Similar funds

CG
Circumference Group Little Rock, Arkansas $44.6M AUM 5.21% 1-Year Est. Return
OC
Optimas Capital Central, Hong Kong $44.5M AUM 24.43% 1-Year Est. Return
ICCON
Investment Counsel Company of Nevada Las Vegas, Nevada $44.5M AUM 21.97% 1-Year Est. Return
PCM
Prentice Capital Management Greenwich, Connecticut $45.7M AUM 2.65% 1-Year Est. Return
CAS
CTC Alternative Strategies Chicago, Illinois $44M AUM 43.15% 1-Year Est. Return
CM
Crestline Management Fort Worth, Texas $46.3M AUM 48.82% 1-Year Est. Return
MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
AB
Aozora Bank Tokyo, Japan $43.6M AUM 1.15% 1-Year Est. Return

Sabby Management's Q1 2023 Portfolio in Review

As of Q1 2023, Sabby Management held 142 positions worth $115M, up 0.69% from $114M the previous quarter. Its ten largest holdings account for 83% of the portfolio.

Sabby Management deployed $6.43M of net new capital in Q1 2023, opening 32 new positions and adding to 15 existing holdings. Its largest new stake was Recon Technology: 219,315 shares worth $1.35M.

By sector, the portfolio is most concentrated in Healthcare at 9.8% of assets, down from 16% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Cocrystal Pharma, an estimated $792K trimmed.

  • Sabby Management's largest Q1 2023 buy was Recon Technology: 219,315 shares worth $1.35M.
  • Sabby Management added most to Akari Therapeutics in Q1 2023, an estimated $1.68M increase.
  • Sabby Management's biggest Q1 2023 reduction was Cocrystal Pharma, cutting an estimated $792K.
  • Sabby Management fully exited Nuvectis Pharma in Q1 2023, selling an estimated $4.41M.
  • Sabby Management's ten largest holdings make up 83% of its $115M portfolio in Q1 2023.
  • Sabby Management opened 32 new positions and closed 53 in Q1 2023.
  • Sabby Management's portfolio value rose 0.69% quarter-over-quarter to $115M.

Based on Sabby Management's 13F filing for Q1 2023, filed 15 May 2023.